Home / Brands / Montana Compounding Pharmacy
Montana Compounding Pharmacy Recalls
12 recalls on record · June 17, 2015 to June 17, 2015 · Drugs
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Mis
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Trimix (PGE1;PHENT;PAP) (N), injectable, (100/10/297) 10UG, 5 mL vial, Rx only, compounded by Montana Compounding Pharma
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Trimix (PGE1;PHENT;PAP) (N), injectable, (100/10/240) 10UG, 5 mL vial, Rx only, compounded by Montana Compounding Pharma
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Trimix (A;PH,PA) (N), injectable, 160 UG-1.2 mg-9.6/ mg/mL, 2 mL vial, Rx only, compounded by Montana Compounding Pharma
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Trimix (A;PH,PA) (N), injectable, 80 UG-0.6 mg-4.8 mg/mL, 1 mL vial, Rx only, compounded by Montana Compounding Pharmacy
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy,
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Glutathione INHALATION (PF), NASAL solution, 100 mg/mL, 3 mL vial, Rx only, dispensed by Montana Compounding Pharmacy, M
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Glutathione INHALATION (PF), solution, 100mg/mL, 4 mL vial, Rx only, dispensed by Montana Compounding Pharmacy, Missoula
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Bimix (PHENT;PAP) (N), solution, (10/300) 1 - 30 mg/mL, injectable, 5ml vial, Rx only, compounded by Montana Compounding
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, M
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Alprostadil (PFE1), solution, 20 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Mis
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
June 17, 2015DrugsFDA
Montana Compounding Pharmacy recalls Alprostadil (PFE1), Solution, 10 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Mis
Hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection